Clinical Omics and Mass Spectrometry

Results of large-scale omics studies have led to significant advances in the biomedical understanding of a variety of biological phenomena, including the development and progression of cancer and other diseases.

Due to its broad-based applicability to detect compounds with a wide range of masses, along with its high sensitivity, mass spectrometry (MS) has been used extensively in a range of omics analyses and applications. In this listicle, we explore the use of MS-based data in a variety of clinical omics settings.

Download this listicle to find out more about:

• Clinical omics and infectious diseases
• Detection and monitoring of food allergens
• Limitations of MS for clinical omics and comparison to other methods